Patient education needs in severe asthma, a pilot study
- PMID: 38491533
- PMCID: PMC10943831
- DOI: 10.1186/s12890-024-02960-8
Patient education needs in severe asthma, a pilot study
Abstract
Background: Severe asthma is characterized by frequent exacerbations, altered lung function, and impaired quality of life. Tailored patient education allows for the improvement of both asthma management and quality of life. Our study aimed to assess the needs of severe asthma patient in therapeutic education, according to previous therapeutic patient education background and asthma phenotype.
Methods: Consecutive patients monitored for severe asthma in a tertiary referral center were considered for inclusion and answered a questionnaire detailing their patient education needs and the topics they would like to discuss. Asthma history, clinical and biological data, and lung function results were recorded.
Results: Fifty-three patients were included and 47 (88.7%) expressed at least one need. The most frequently selected topics were "life with asthma" (83%), "treatment use" (68%), and "exacerbation management" (60%), independent of previous participation in a patient education program dedicated to asthma. Patients of older age at inclusion, uncontrolled asthma, and T2-high phenotypes were associated with different profiles of patient education needs.
Conclusion: Our study identified frequent and various patient educational needs among severe asthmatics, highlighting the importance of an in-depth assessment of severe asthmatics expectations and the crucial need for the development of dedicated educational tools.
Keywords: Age; Eosinophils; Patient education; Phenotype; Severe asthma.
© 2024. The Author(s).
Conflict of interest statement
S. Dury reports lecture honoraria from Boehringer Inhelheim and Sanofi-Aventis; outside the submitted work. V. Dormoy reports lecture honoraria from Chiesi and AstraZeneca; outside the submitted work. G. Deslée reports personal fees from Chiesi, GSK and AstraZeneca; outside the submitted work. J.M. Perotin reports lecture honoraria from AstraZeneca, support for attending meetings from AstraZeneca and Chiesi, and membership of working groups and associations receiving financial support from AstraZeneca, Chiesi, Novartis, and Sanofi; outside the submitted work. There are no further conflicting interests to disclose.
Figures
References
-
- Roche N, Garcia G, de Larrard A, Cancalon C, Bénard S, Perez V, et al. Real-life impact of uncontrolled severe asthma on mortality and healthcare use in adolescents and adults: findings from the retrospective, observational RESONANCE study in France. BMJ Open. 2022;12(8):e060160. doi: 10.1136/bmjopen-2021-060160. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
